Paolo Tarantino: A pleasure to co-host the latest ESMO Open podcast with Giuseppe Curigliano
Paolo Tarantino shared a post by ESMO – European Society for Medical Oncology on LinkedIn, adding:
”Don’t miss the latest ESMO Open podcast, with Sara Hurvitz and Nancy Lin discussing the latest data on the intracranial activity of ADCs for metastatic breast cancer. A pleasure to co-host the podcast with Giuseppe Curigliano.”
Quoting ESMO – European Society for Medical Oncology’s post:
”Latest podcast ESMO Open Editor-in-Chief Giuseppe Curgliano presents a discussion between Sara Hurwitz and Nancy Lin, with ESMO Open Associate Editor Paolo Tarantino, following the publication of their articles on antibody-drug conjugate activity in patients with HER2-positive breast cancer.”
Source: Paolo Tarantino/LinkedIn and ESMO – European Society for Medical Oncology/LinkedIn
Dr. Paolo Tarantino, MD researcher, holds positions at both the European Institute of Oncology in Milan, Italy, and the Dana-Farber Cancer Institute in Boston, MA, Specializing in breast cancer. Currently, Dr. Tarantino is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan. His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a robust publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field. Dr. Tarantino’s dedication and innovative approach contribute significantly to the advancement of breast cancer treatment and research.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023